These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35716825)

  • 1. Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study.
    Apeland T; Ushakova A; Mansoor MA; Furriol J; Jonsson G; Marti HP
    Free Radic Biol Med; 2022 Aug; 188():62-70. PubMed ID: 35716825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
    Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T
    Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating inflammation-related factors are correlated with systemic redox status in IgA nephropathy; a case-control study.
    Apeland T; Mansoor MA; Furriol J; Ushakova A; Jonsson G; Stangeland KW; Marti HP
    Free Radic Biol Med; 2020 Aug; 155():10-18. PubMed ID: 32428564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation analysis of cofilin-1 with renal prognosis in primary IgA nephropathy.
    Zhao RB; Xu YS; Li XH; Wei MJ; Deng Y; Peng X; Pan L
    BMC Nephrol; 2024 Sep; 25(1):289. PubMed ID: 39227817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
    BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.
    Oh YJ; An JN; Kim CT; Yang SH; Lee H; Kim DK; Joo KW; Paik JH; Kang SW; Park JT; Lim CS; Kim YS; Lee JP
    PLoS One; 2015; 10(7):e0132826. PubMed ID: 26177311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal expression of advanced oxidative protein products predicts progression of renal fibrosis in patients with IgA nephropathy.
    Wang J; Liang M; Xu J; Cao W; Wang GB; Zhou ZM; Tian JW; Jia N; Zhang Z; Nie J; Liu Y; Hou FF
    Lab Invest; 2014 Sep; 94(9):966-77. PubMed ID: 25068662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping novel immunogenic epitopes in IgA nephropathy.
    Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on predicting renal progression in IgA nephropathy.
    Barbour S; Reich H
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):214-220. PubMed ID: 29432215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
    J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J; Bauer F; Fitzner C; Hilgers RD; Seibert F; Babel N; Doevelaar A; Eitner F; Floege J; Rauen T; Westhoff TH
    Kidney Blood Press Res; 2018; 43(5):1563-1572. PubMed ID: 30347407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Medjeral-Thomas NR; Lomax-Browne HJ; Beckwith H; Willicombe M; McLean AG; Brookes P; Pusey CD; Falchi M; Cook HT; Pickering MC
    Kidney Int; 2017 Oct; 92(4):942-952. PubMed ID: 28673452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.
    Descamps-Latscha B; Witko-Sarsat V; Nguyen-Khoa T; Nguyen AT; Gausson V; Mothu N; Cardoso C; Noël LH; Guérin AP; London GM; Jungers P
    Kidney Int; 2004 Oct; 66(4):1606-12. PubMed ID: 15458457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.